Research Analysts’ new coverage for Monday, October 23rd:

Guggenheim started coverage on shares of Aerie Pharmaceuticals (NASDAQ:AERI). Guggenheim issued a buy rating on the stock.

SunTrust Banks, Inc. began coverage on shares of BioTelemetry (NASDAQ:BEAT). The firm issued a buy rating on the stock.

Guggenheim began coverage on shares of Biogen (NASDAQ:BIIB). They issued a buy rating on the stock.

Guggenheim assumed coverage on shares of Celgene Corporation (NASDAQ:CELG). The firm issued a buy rating on the stock.

Guggenheim assumed coverage on shares of Curis (NASDAQ:CRIS). The firm issued a buy rating on the stock.

Cantor Fitzgerald initiated coverage on shares of CytomX Therapeutics (NASDAQ:CTMX). They issued a buy rating and a $35.00 price target on the stock.

Deutsche Bank AG assumed coverage on shares of Hanesbrands (NYSE:HBI). They issued a buy rating and a $29.00 target price on the stock.

Guggenheim assumed coverage on shares of The Medicines (NASDAQ:MDCO). Guggenheim issued a buy rating on the stock.

Guggenheim initiated coverage on shares of Ocular Therapeutix (NASDAQ:OCUL). The firm issued a buy rating on the stock.

Deutsche Bank AG started coverage on shares of PVH Corp. (NYSE:PVH). They issued a hold rating and a $131.00 price target on the stock.

Needham & Company LLC initiated coverage on shares of Qualys (NASDAQ:QLYS). Needham & Company LLC issued a buy rating on the stock.

Guggenheim assumed coverage on shares of Regeneron Pharmaceuticals (NASDAQ:REGN). Guggenheim issued a buy rating on the stock.

Needham & Company LLC started coverage on shares of Rapid7 (NASDAQ:RPD). The firm issued a buy rating on the stock.

Guggenheim assumed coverage on shares of Seattle Genetics (NASDAQ:SGEN). The firm issued a buy rating on the stock.

Guggenheim started coverage on shares of Spectrum Pharmaceuticals (NASDAQ:SPPI). They issued a buy rating on the stock.

Receive News & Ratings for Aerie Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aerie Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.